作者：
Albright,C.F. [1]
;
Dockens,R.C. [2]
;
Meredith,J.E. [3]
;
Olson,R.E. [4]
;
Slemmon,R. [5]
;
Lentz,K.A. ;
Wang,J.-S. ;
Denton,R.R. ;
Pilcher,G. ;
Rhyne,P.W. ;
Raybon,J.J. ;
Barten,D.M. ;
Burton,C. ;
Toyn,J.H. ;
Sankaranarayanan,S. ;
Polson,C. ;
Guss,V. ;
White,R. ;
Simutis,F. ;
Sanderson,T. ;
Gillman,K.W. ;
Starrett,J.E. ;
Bronson,J. ;
Sverdlov,O. ;
Huang,S.-P. ;
Castaneda,L. ;
Feldman,H. ;
Coric,V. ;
Zaczek,R. ;
Macor,J.E. ;
Houston,J. ;
Berman,R.M. ;
Tong,G.
作者单位：
Research and Development, Bristol-Myers Squibb, Lawrenceville, NJ, United States
[1]
Research and Development, Bristol-Myers Squibb, Department of Drug Safety Evaluation, Evansville
[2]
Research and Development, Bristol-Myers Squibb, Pennington, NJ, United States
[3]
Research and Development, Bristol-Myers Squibb, Wallingford, CT, United States
[4]
Research and Development, Bristol-Myers Squibb, Wallingford, CT, United States, Bristol-Myers
[5]
发布时间
2014-01-21
换一批
